ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,990Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 807

$922K Total Retail Price of All Prescriptions

Rank: 10 out of 807

356 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 356 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 13,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 647 598 1 1
LISINOPRIL 552 519 2 2
LEVOTHYROXINE SODIUM 515 466 3 3
WARFARIN SODIUM 463 448 4 10
AMLODIPINE BESYLATE 460 447 5 5
METOPROLOL SUCCINATE 409 384 6 13
FUROSEMIDE 375 365 7 6
HYDROCHLOROTHIAZIDE 349 325 8 9
METFORMIN HCL 345 320 9 12
OMEPRAZOLE 334 276 10 4
ALENDRONATE SODIUM 284 240 11 20
METOPROLOL TARTRATE 261 259 12 8
DIGOXIN 257 257 13 41
CITALOPRAM HBR 205 185 14 17
NEXIUM 195 150 15 68
DONEPEZIL HCL 185 185 16 31
DIOVAN 185 177 16 46
NAMENDA 184 184 18 54
POTASSIUM CHLORIDE 178 178 19 18
POLYETHYLENE GLYCOL 3350 174 162 20 40
TRAMADOL HCL 169 152 21 19
CYMBALTA 163 147 22 73
GABAPENTIN 160 145 23 16
RANITIDINE HCL 158 146 24 34
CLOPIDOGREL 157 150 25 47
KLOR-CON M20 156 156 26 83
CRESTOR 153 146 27 32
JANUVIA 152 140 28 79
LOSARTAN POTASSIUM 143 131 29 14
ISOSORBIDE MONONITRATE ER 142 140 30 36
ATENOLOL 136 110 31 7
TRIAMTERENE-HCTZ 128 128 32 29
ADVAIR DISKUS 114 102 33 33
ATORVASTATIN CALCIUM 114 103 33 11
ZETIA 113 103 35 59
PLAVIX 111 107 36 60
FAMOTIDINE 105 100 37 90
BUMETANIDE 102 97 38 137
PAROXETINE HCL 100 89 39 49
LANTUS 99 99 40 45
NOVOLOG 94 94 41 84
CARBIDOPA-LEVODOPA 93 93 42 64
LOVASTATIN 91 91 43 39
ALLOPURINOL 85 76 44 26
NITROGLYCERIN PATCH 84 84 45 213
PRAVASTATIN SODIUM 82 82 46 21
LIDODERM 81 81 47 96
ROPINIROLE HCL 75 67 48 95
SERTRALINE HCL 73 64 49 22
LANTUS SOLOSTAR 72 69 50 42
CARVEDILOL 70 70 51 35
ESCITALOPRAM OXALATE 70 66 51 115
UNIFINE PENTIPS 67 66 53 293
OXYBUTYNIN CHLORIDE ER 67 55 53 118
PREDNISONE 67 63 53 24
DILTIAZEM 24HR ER 64 64 56 189
CLONIDINE HCL 63 63 57 82
GLYBURIDE 62 62 R 58 80
HYDRALAZINE HCL 61 61 59 62
HYDROCODONE-ACETAMINOPHEN 61 55 S3 59 15
NYSTOP 60 60 61 125
LEVEMIR 59 59 62 196
HUMALOG 58 58 63 124
SPIRIVA 57 57 64 50
JANUMET 55 55 65 245
INSULIN SYRINGE 53 43 66 102
DILTIAZEM ER 52 36 67 109
BENAZEPRIL HCL 52 52 67 142
CALCITRIOL 51 39 69 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.